Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
Cell Res 21(1):86102 Shirai Y, Fujita Y, Hashimoto R, Ohi K, Yamamori H, Yasuda Y, Takeda M (2015) Dietary intake of sulforaphane-rich broccoli sprout extracts during juvenile and adolescence can prevent phencyclidine-induced cognitive deficits at adulthood
Ensure you are eating slowly and in small amounts
Tng cng hng ro bo v da, ngn nga tc hi ca tia UV v nhim mi trng
If you're in town for the holidays, head straight to the Sweets Stroll Festival